title: Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo.
abstract: The role of nitric oxide (NO) in microvascular permeability is controversial, in part because the regulation of its endothelial constitutive synthase, eNOS, has been studied in vitro but not in vivo. Our study was designed to detect the morphologic and functional presence of eNOS and to test whether eNOS could be phosphorylated by platelet-activating factor (PAF), an agent that induces hyperpermeability. Immunocytochemistry was applied using human anti-eNOS antibodies in the hamster cheek pouch (hcp). The hcp microvessels demonstrated positive reaction products in the endothelium. The functional presence of eNOS in hcp was investigated by topical application of 10(-7) M PAF to the hcp and by measuring NO production by chemiluminescence. The mean baseline value of NO release was 63.3 +/- 6.9 pmol/ml (mean +/- SE). Application of PAF led to an increase in mean NO release to 120.8 +/- 31.2 pmol/ml (P < 0.05). In another series of experiments, 10(-7) M PAF was applied topically to hcp preincubated with [(32)P]orthophosphoric acid. Immunoprecipitation and Western blots detected (32)P-labeled bands that migrated with the mobility of positive eNOS indicating phosphorylated eNOS protein. The intensity of the radioactive bands was evaluated by computer-assisted image analysis. Comparison of the net band intensities yielded a mean PAF-treated/control ratio of 1.6 +/- 0.1. Our data demonstrate the morphologic and functional presence of eNOS in the microcirculation. The data also provide evidence that the function of microvascular eNOS is subject to regulation by phosphorylation.
authors.affiliation: Program in Vascular Biology, UMDNJ-New Jersey Medical School, Newark, New Jersey, 07013, USA.
authors.forename: W N
authors.initials: WN
authors.lastname: Durán
authors.forename: A
authors.initials: A
authors.lastname: Seyama
authors.forename: K
authors.initials: K
authors.lastname: Yoshimura
authors.forename: D R
authors.initials: DR
authors.lastname: González
authors.forename: P I
authors.initials: PI
authors.lastname: Jara
authors.forename: X F
authors.initials: XF
authors.lastname: Figueroa
authors.forename: M P
authors.initials: MP
authors.lastname: Borić
mesh_terms: D000818:Animals; D006224:Cricetinae; D006801:Humans; D008297:Male; D008647:Mesocricetus; D008833:Microcirculation / Q000187:drug effects* / Q000502:physiology*; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000502:physiology*; D052250:Nitric Oxide Synthase Type III; D010766:Phosphorylation; D010972:Platelet Activating Factor / Q000494:pharmacology*
chemical_list: D010972:Platelet Activating Factor; D009569:Nitric Oxide; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III